Clinical Trials
21 trialsNCT06369259 2026-05-20
Open-label Phase 2 Study of Avutometinib (RAF/MEK Clamp) in Combination With Defactinib (FAK Inhibitor) and Cetuximab in Patients With Unresectable, Anti-EGFR-Refractory Advanced Colorectal Cancer
M.D. Anderson Cancer Center
Phase 2 Recruiting
NCT07391618 2026-02-06
Clinical Study on the First-line Treatment of Advanced Colorectal Cancer With Simultaneous Infusion of Levozolinate for Injection and 5-FU
Chinese PLA General Hospital
Phase 2 Recruiting
NCT07281157 2025-12-30
Irinotecan Liposome Plus Capecitabine and Enronsubemab Combined With Short-course Radiotherapy for Neoadjuvant Treatment of Locally Advanced Rectal Cancer
Tianjin Medical University Cancer Institute and Hospital
Phase 2 Recruiting
NCT06885385 2025-06-24
A Phase 2 Study Evaluating the Safety and Efficacy of JS207 With or Without JS015 in Combination With Chemotherapy in Patients With Colorectal Cancer
Shanghai Junshi Bioscience Co., Ltd.
Phase 2 Recruiting
NCT07000305 2025-06-02
SUPβORT
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase 2 Not yet recruiting
NCT06838546 2025-02-20
A Multicenter, Open Phase IIb Clinical Study to Evaluate the Efficacy and Safety of B1962 Injection in the Treatment of Advanced Colorectal Cancer
Tasly Biopharmaceuticals Co., Ltd.
Phase 2 Not yet recruiting
NCT02619435 2023-03-24
STREAM
National Cancer Institute, Naples
Phase 2 Unknown
NCT05364489 2022-05-20
Efficacy, Safety and Exploratory Clinical Study of Bevacizumab Combined With Oxaliplatin and TAS-102 in First-line Treatment of Advanced Colorectal Cancer
The First Affiliated Hospital of Zhengzhou University
Phase 2 Not yet recruiting
NCT04764006 2021-11-04
Surufatinib Combined With Sintilimab for Advanced MSS-Type Colorectal Cancer : a Phase II Study
Fujian Cancer Hospital
Phase 2 Unknown
NCT03126071 2021-08-30
Raltitrexed-based Chemotherapy Plus Bevacizumab in Retreated Patients With Advanced Colorectal Cancer
Jiangsu Cancer Institute & Hospital
Phase 2 Unknown
NCT04324476 2021-08-30
A Study of Bevacizumab Plus XELOX/XELIRI for First-line Treatment in Unresectable Advanced Colorectal Cancer
Jiangsu Cancer Institute & Hospital
Phase 2 Unknown
NCT02227667 2021-06-18
Evaluate the Efficacy of MEDI4736 in Immunological Subsets of Advanced Colorectal Cancer
Memorial Sloan Kettering Cancer Center
Phase 2 Completed
NCT03311750 2021-06-07
A-REPEAT
Hellenic Cooperative Oncology Group
Phase 2 Terminated
NCT03427268 2021-05-24
Clinical Trial of PM60184 in Advanced Colorectal Cancer After Standard Treatment
PharmaMar
Phase 2 Completed
NCT04734249 2021-02-02
Second-line Surufatinib Combined With Chemotherapy in Advanced CRC
Fujian Cancer Hospital
Phase 2 Unknown
NCT00637091 2021-01-22
Efficacy Analysis of Cetuximab Plus Irinotecan in Patients With Wild-type KRAS Without Regard to Epidermal Growth Factor Receptor (EGFR) Expressions
Asan Medical Center
Phase 2 Completed
NCT00309179 2017-09-14
A Phase II Study of the Safety and Efficacy of E7820 Plus Cetuximab in Colorectal Cancer, Preceded by a Run-in Study in Advanced Solid Tumors
Eisai Inc.
Phase 2 Completed
NCT00824161 2012-04-23
Phase II Study of TAS-109 to Treat Advanced Colorectal Cancer
Taiho Pharmaceutical Co., Ltd.
Phase 2 Terminated
NCT00853684 2009-09-18
OXCE
Shanghai Jiao Tong University School of Medicine
Phase 2 Unknown
NCT00972465 2009-09-07
Study of Nimotuzumab to Treat Colorectal Cancer
Peking University
Phase 2 Unknown
NCT00286000 2007-12-28
High Dose Simplified Folfiri in Advanced Colorectal Cancer: a Multicentre Phase II Study
University Hospital, Ghent
Phase 2 Completed